(Q40559637)

21 September 2017

Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience (English)

1 reference

21 September 2017

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

14 March 2024

1 reference

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

T-cell acute lymphoblastic leukemia

1 reference

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

14 March 2024

author name string

Virginia Kimball Dalton

4

1 reference

21 September 2017

Leslie Lehmann

6

1 reference

21 September 2017

John M. Goldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Lewis B. Silverman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Donna E. Levy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Richard D. Gelber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Harvey J. Cohen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Stephen E. Sallan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

Barbara L. Asselin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512392

14 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

21 September 2017

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.10.116

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Journal of Clinical Oncology

14 March 2024

published in

1 reference

21 September 2017

21

1 reference

21 September 2017

3616-3622

1 reference

21 September 2017

19

1 reference

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

21 September 2017

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

T-cell acute lymphoblastic leukemia in children.

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Induction failure in acute lymphoblastic leukemia of childhood

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Nonparametric Estimation from Incomplete Observations

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Genetic instability is associated with histological transformation of follicle center lymphoma

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report

14 March 2024

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

14 March 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Second malignancies in patients treated for childhood acute lymphoblastic leukemia

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.10.116

14 March 2024

Identifiers

1 reference

21 September 2017

1 reference